← All Nanobiotix SA filings

Nanobiotix SA Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
NBTX
Nanobiotix SA
SCHEDULE: Invus Group Entities Disclose 9.4% Stake in Nanobiotix
Invus Public Equities, L.P. and affiliated entities have reported beneficial ownership of 9.4% of Nanobiotix S.A.'s ordinary shares, including shares issuable from warrants.
NASDAQ
NBTX
Nanobiotix SA
SCHEDULE: Qatar Investment Authority Ups Nanobiotix Stake to 7%
Qatar Investment Authority has disclosed an increased beneficial ownership of Nanobiotix SA's Depositary Receipts S ADR to 7.0%, totaling 3,532,517 shares.
NASDAQ
NBTX
Nanobiotix SA
SCHEDULE 13G: Invus Public Equities Discloses 8.9% Passive Stake in Nanobiotix S.A.
Invus Public Equities, L.P. and its affiliated entities have filed a Schedule 13G, reporting a passive beneficial ownership of 8.9% in Nanobiotix S.A. as of December 31, 2023.
NASDAQ
NBTX
Nanobiotix SA
SCHEDULE 13G/A: Baillie Gifford & Co Discloses 4.05% Stake in Nanobiotix S.A.
Investment adviser Baillie Gifford & Co has reported a 4.05% beneficial ownership stake in Nanobiotix S.A. as of December 31, 2024.